NewTimeSpace News: On 17 August 2026, HKEX (00388.HK) announced that the board has approved a three-year renewal of the contract of Group Chief Executive Bonnie Y Chan, from 1 March 2027 to 28 February 2030, with the reappointment approved by the Securities and Futures Commission; her remuneration package includes a basic annual salary of HKD 12 million plus discretionary bonuses and share awards.
NewTimeSpace News: On 17 August 2026, HAIXI PHARMA (02637.HK) announced that its self-developed oral small-molecule innovative drug HX9428 has been granted Fast Track Designation by the US FDA for the treatment of neovascular age-related macular degeneration (nAMD); HX9428 has completed Phase I clinical studies, is advancing Phase II studies, and has received FDA approval to conduct a Phase II clinical trial in the United States.
August 17, 2026, HANXBIO-B(03378.HK) released its Interim Report for the period ended December 31, 2026
August 17, 2026, BILLION IND(02299.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 12.71 billion, increased by 34.03% YoY
August 17, 2026, ZHIDA TECH(02650.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 340.32 million, decreased by 13.33% YoY
August 17, 2026, STAR SPORTS MED(01609.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 163.43 million, increased by 21.62% YoY
August 17, 2026, COWELL(01415.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 1.6 billion, increased by 17.97% YoY
August 17, 2026, CONANT OPTICAL(02276.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.17 billion, increased by 7.64% YoY
August 17, 2026, HWORLD-S(01179.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 13.12 billion, increased by 10.96% YoY
August 17, 2026, GUOQUAN(02517.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 3.95 billion, increased by 21.83% YoY
NewTimeSpace News: On 17 August 2026, MICOT PHARMA-B (02335.HK) announced that three studies on its key product XTL6001 have been accepted for presentation at international academic conferences: two abstracts were accepted at EASD 2026 (including an oral presentation and a short oral discussion) and one at ASN Kidney Week 2026 as a poster; XTL6001 is a GLP-1R/GCGR/MasR triple-target agonist approved for clinical studies in both China and the US, being developed for weight management, proteinuric CKD and MASH.
NewTimeSpace News: On 17 August 2026, GOLDENPOWER (03919.HK) announced the completion of the subscription of new shares under the general mandate, with 6,492,000 subscription shares allotted and issued at HKD 0.65 per share, representing approximately 14.3% of the enlarged issued share capital, and the subscriber becoming a substantial shareholder; net proceeds of approximately HKD 4.1 million will be used mainly to repay due bank facilities.
NewTimeSpace News: On 17 August 2026, CCT FORTIS (00138.HK) issued a profit warning, expecting a consolidated net loss attributable to owners of the company of between approximately HKD 120 million and HKD 140 million for the six months ended 30 June 2026, narrowing from approximately HKD 210 million in the same period of 2025, mainly due to a decrease of approximately HKD 73 million in property impairment losses and approximately HKD 22 million in administrative expenses following a subsidiary disposal.
SINOPEC CORP(00386.HK) will spend CNY 6.5 million to repurchase 1.3 million shares on Aug 17, 2026 .
MIDEA GROUP(00300.HK) will spend CNY 110.21 million to repurchase 1.33 million shares on Aug 17, 2026 .
August 17, 2026, SEER TECH(06106.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 264.39 million, increased by 67.49% YoY
